1. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) Module I, pharmacovigilance systems and their quality systems.
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129132.pdf
. Accessed 6 Jan 2017.
2. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP): Module IX—signal management. 2012.
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129138.pdf
. Accessed 15 February 2017.
3. Leveson N. Engineering a safer world: systems thinking applied to safety. Cambridge: MIT Press; 2011.
4. Pawlicki T, Samost A, Brown DW, et al. Application of systems and control theory-based hazard analysis to radiation oncology. Med Phys. 2016;43(3):1514–30.
5. Dokas IM, Feehan J, Imran S. EWaSAP: an early warning sign identification approach based on a systemic hazard analysis. Saf Sci. 2013;58:11–26.